Galderma's Bill Andriopoulos, PhD, discusses Dysport's real-world success and evolving trends in aesthetic injectables, emphasizing patient satisfaction and innovative treatments.
Bill Andriopoulos, PhD
Advertisement
Bill Andriopoulos, PhD, is the Head of Global Medical Affairs at Galderma.
Articles by Bill Andriopoulos, PhD
Discover insights from Bill Andriopoulos, PhD, on Relfydess, a groundbreaking neuromodulator utilizing PEARL Technology for enhanced efficacy and safety.
Advertisement
Latest Updated Articles
Bill Andriopoulos, PhD: Inside the PEARL Technology and Phase 3 Results of RelfydessPublished: January 28th 2026 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
5